January 12-15 | San Francisco Marriott Marquis
January 12-16 | Virtual
Bridgewest Group
Private investment group, with $3B USD fund. Primarily Life Science and Technology. Life science portfolio includes 15 companies, including therapeutic assets, CDMO services, diagnostics, and tools. Emphasis on drug substance, drug product, cell therapy.